New Research Uncovers How Fungal Diseases Adapt to Survive in Humans

Article

A new study from the Westmead Institute for Medical Research has uncovered how serious fungal infections grow in humans by conserving phosphate, highlighting a possible target for treatment.

Cryptococcus neoformans is a potentially life-threatening invasive fungal disease that infects people with weakened immune systems, such as cancer patients and organ transplant recipients. The fungus needs phosphate to grow and sustain an infection in its host, as phosphate is essential for functions such as cell division.

Researchers found that, in environments with limited phosphate, Cryptococcus neoformans remodels lipids -- fatty acids in the cell membrane -- to release phosphate.

Lead researcher, associate professor Julie Djordjevic, said, "This is the first time that this strategy of conserving phosphate has been described in a human fungal pathogen. Fungi encounter phosphate starvation when they infect humans. However, fungal infections are quite clever, and have unique strategies to conserve phosphate when it becomes scarce. We found Cryptococcus neoformans conserves phosphate by activating a gene, BTA1, which encodes an enzyme that produces betaine lipids. Production of these betaine lipids allows the fungal pathogen to recycle phosphate from the lipids it normally produces, helping it to survive and spread. Fungi that were missing the BTA1 gene grew more slowly than cells with the gene and were less able to cause disease in animal infection models, indicating the essential role of phosphate conservation in the development of Cryptococcus neoformans infections."

Cryptococcus neoformans initially infects the lungs, where it can spread to the brain, causing the life-threatening condition, Cryptococcal meningitis. Invasive fungal diseases including those caused by Cryptococcus neoformans cause 1.6 million deaths worldwide each year.

Djordjevic said the high rates of mortality are, partly, due to a lack of new treatments. "The growing emergence of drug resistant strains of fungi, as well as a lack of effective existing treatments, means we need new therapies to combat invasive fungal diseases. Now that we understand how Cryptococcus neoformans conserves phosphate, we can investigate how we can prevent this process from occurring to stop the growth and spread of infection."

Source:  Westmead Institute for Medical Research

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content